Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Type of study
Language
Affiliation country
Publication year range
1.
Cell Physiol Biochem ; 55(S2): 71-88, 2021 Jul 10.
Article in English | MEDLINE | ID: mdl-34242500

ABSTRACT

Psychological stress is an important factor involved in disease manifestations of human papillomavirus (HPV) infection, and it can participate in HPV-associated carcinogenesis. The impact or effect which stress can have (exert) depends on a person's genetic pool, experiences and behaviors. Due to inconsistencies in some study results, this issue remains a subject of research. Concerning the course of HPV manifestations, it has been observed that a higher number of life stressors in at least the previous 6 months, the absence of social support and the types of personal coping mechanisms employed, all influence HPV progression. In women with cervical dysplasia, a connection between greater stress experiences and dysregulation of specific immune responses has been observed. Once HPV enters a cell via the α6 integrin there are three possible sequences: latent infection, subclinical infection, and clinically manifest disease. HPV proliferation in differentiated epithelial cells induces morphologically cytopathic changes (koilocytosis, epidermal thickening, hyperplasia, hyperkeratosis). Oncogenic transformation requires the integration of the virus genome into the host genome. In doing so, DNA in the E1 region of E2 breaks down, leading to transcription disorders of E6 and E7. For the formation of irreversible malignancy, the following sequence is necessary: initial expression of E6 and E7 genes followed by suppression of apoptosis and the stabile expression of E6 and E7 proteins that protect transformed cells from apoptosis. A successful immune response is characterized by a strong, local cell-mediated immune response. Several factors are important for the regression of HPV manifestation/infection, among which is psychological stress which can prolong the duration and severity of HPV disease. Stress hormones may reactivate latent tumor viruses, stimulate viral oncogene expression, and inhibit antiviral host responses. In the regression of HPV infection, increased activity of Th1 cells was observed. However, during psychosocial stress, a decrease in the Th1 type of immune response is seen, and there is a shift towards a Th2 response. Understanding perceived stress and biological changes in stress, as well as the evaluation of immune parameters, gives researchers a better picture of how stress influences HPV infections and how to improve disease management and outcomes.


Subject(s)
Papillomaviridae/physiology , Papillomavirus Infections/psychology , Stress, Psychological , Carcinogenesis , DNA, Viral/genetics , DNA, Viral/metabolism , Epithelial Cells/cytology , Epithelial Cells/virology , Humans , Nervous System/metabolism , Nervous System/virology , Papillomaviridae/genetics , Papillomavirus Infections/immunology , Papillomavirus Infections/pathology , Pituitary-Adrenal System/metabolism , Pituitary-Adrenal System/virology
2.
Front Med ; 14(5): 533-541, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32367431

ABSTRACT

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), has caused a global pandemic in only 3 months. In addition to major respiratory distress, characteristic neurological manifestations are also described, indicating that SARS-CoV-2 may be an underestimated opportunistic pathogen of the brain. Based on previous studies of neuroinvasive human respiratory coronaviruses, it is proposed that after physical contact with the nasal mucosa, laryngopharynx, trachea, lower respiratory tract, alveoli epithelium, or gastrointestinal mucosa, SARS-CoV-2 can induce intrinsic and innate immune responses in the host involving increased cytokine release, tissue damage, and high neurosusceptibility to COVID-19, especially in the hypoxic conditions caused by lung injury. In some immune-compromised individuals, the virus may invade the brain through multiple routes, such as the vasculature and peripheral nerves. Therefore, in addition to drug treatments, such as pharmaceuticals and traditional Chinese medicine, non-pharmaceutical precautions, including facemasks and hand hygiene, are critically important.


Subject(s)
Betacoronavirus , Coronavirus Infections , Nervous System Diseases , Nervous System , Pandemics , Pneumonia, Viral , Betacoronavirus/pathogenicity , Betacoronavirus/physiology , COVID-19 , Coronavirus Infections/immunology , Coronavirus Infections/physiopathology , Coronavirus Infections/virology , Humans , Nervous System/physiopathology , Nervous System/virology , Nervous System Diseases/etiology , Nervous System Diseases/immunology , Nervous System Diseases/therapy , Pneumonia, Viral/immunology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/virology , SARS-CoV-2
3.
Virology ; 432(2): 417-26, 2012 Oct 25.
Article in English | MEDLINE | ID: mdl-22819834

ABSTRACT

Enterovirus 71 (EV71) is a major pathogen that causes hand-foot-mouth disease (HFMD). Our previous studies have demonstrated that the complete process of pathogenesis, which may include tissue damage induced by host inflammatory responses and direct tissue damage caused by viral infection, can be observed in the central nervous system (CNS) of animals infected in the laboratory with EV71. Based on these observations, the neuropathogenesis and protein expression profiles in the thalamic tissues of EV71-infected animals were further analyzed in the present study. Changes in protein expression profiles following immunization with the inactivated EV71 vaccine followed by virus challenge were observed and evaluated, and their physiological roles in viral pathogenesis are discussed. Taken together, the results of these experiments provide evidence regarding the neuropathogenesis and molecular mechanisms associated with EV71 infection and identify several protein indicators of pathogenic changes during viral infection.


Subject(s)
Enterovirus A, Human/immunology , Enterovirus A, Human/pathogenicity , Enterovirus Infections/immunology , Gene Expression Profiling , Thalamus/pathology , Viral Vaccines/administration & dosage , Animals , Animals, Newborn , Antibodies, Viral/blood , Enterovirus Infections/prevention & control , Enterovirus Infections/virology , Immunization , Inflammation/immunology , Macaca mulatta , Nervous System/pathology , Nervous System/virology , Thalamus/metabolism , Thalamus/virology , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/immunology , Viral Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL